Table 1.
Selected baseline demographic and clinical variables among CHOICE participants by obesity status
| Variable | Overall(N=482) | Yes Obesity(N=212) | No Obesity(N=270) | Pa |
|---|---|---|---|---|
|
| ||||
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Age (mean ± SD years) | 39 ± 12 | 41 ± 11 | 37 ± 13 | <0.001 |
| CGI-BP Severity | 4.5 ± 0.9 | 4.4 ± 0.8 | 4.6 ± 0.9 | 0.061 |
| BISS total | 56.1 ± 18.8 | 55.8 ± 19.7 | 56.4 ± 18.2 | 0.736 |
| BISS depression | 37.6 ± 14.1 | 37.4 ± 14.1 | 37.7 ± 14.1 | 0.792 |
| LIFE-RIFT total | 14.2 ± 3.4 | 14.3 ± 3.3 | 14.2 ± 3.4 | 0.856 |
| Q-LES-Q overall | 41.6 ± 24.5 | 42.6 ± 24.5 | 40.8 ± 24.6 | 0.429 |
|
| ||||
| % | % | % | ||
|
| ||||
| Female gender | 58.8 | 64.6 | 54.1 | 0.021 |
| Race | 0.025 | |||
| White | 72.2 | 71.7 | 72.6 | |
| Black | 19.9 | 23.6 | 17.0 | |
| Other | 7.9 | 4.7 | 10.4 | |
| Married/Living as Married | 31.1 | 37.7 | 25.9 | 0.005 |
| Any Anxiety Disorder | 58.2 | 61.8 | 54.9 | 0.132 |
| Binge Eating | 25.6 | 30.6 | 21.6 | 0.026 |
| Weight Gain Medicationb | 21.8 | 24.1 | 20.0 | 0.284 |
a
P is based on either t-test (continuous) or chi-square test (categorical) between obese and non-obese groups.
b
Weight-gain medication = amitriptyline, aripiprazole, clomipramine, clozapine, doxepin, imipramine, lithium, mirtazepine, olanzapine, quetiapine, risperidone, and valproate.
Key: BISS = Bipolar Inventory of Symptoms Scale; CGI-BP Severity = Clinical Global Impression Severity Scale for Bipolar Disorder; CI = confidence interval; LIFE-RIFT = Life-Range of Impaired Functioning Tool; Q-LES-Q = Quality-of-Life Enjoyment and Satisfaction Questionnaire